XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 16,947 $ 13,586 $ 44,760 $ 42,503
General and administrative 4,941 6,042 15,520 18,727
Total operating expenses 21,888 19,628 60,280 61,230
Loss from operations (21,888) (19,628) (60,280) (61,230)
Other income (expense):        
Interest income, net 2,615 2,984 8,368 8,005
Other income, net 121 4 103 24
Total other income 2,736 2,988 8,471 8,029
Loss before provision for income taxes (19,152) (16,640) (51,809) (53,201)
Provision (benefit) for income taxes 74   (16,100) 3
Net loss (19,226) (16,640) (35,709) (53,204)
Unrealized gain (loss) on available for sale investments, net of tax 591 (27) 211 90
Foreign currency translation gain (loss) 4   (25)  
Total other comprehensive income (loss) 595 (27) 186 90
Total comprehensive loss $ (18,631) $ (16,667) $ (35,523) $ (53,114)
Net loss per share - basic $ (0.37) $ (0.34) $ (0.69) $ (1.13)
Net loss per share - diluted $ (0.37) $ (0.34) $ (0.69) $ (1.13)
Weighted-average common shares outstanding - basic 51,574,027 49,047,296 51,499,818 46,889,921
Weighted-average common shares outstanding - diluted 51,574,027 49,047,296 51,499,818 46,889,921